Studies examining the hypothesis that ESAs directly stimulate tumor growth by activating canonical EpoR signaling pathways (i.e. PI3K/AKT, RAS/RAF/ERK and JAK/STAT) on tumor cells have reported conflicting results. This evidence concerns the gene EPOR and neoplasm.